| Dr Huda Y Alsheikh, MD | |
|
8881 Fletcher Pkwy Ste 200, La Mesa, CA 91942-3135 | |
| (619) 464-6434 | |
| (619) 464-5109 |
| Full Name | Dr Huda Y Alsheikh |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 8881 Fletcher Pkwy Ste 200, La Mesa, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487746855 | NPI | - | NPPES |
| 6384609 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MA60408 (New Jersey) | Secondary |
| 208000000X | Pediatrics | C133872 (California) | Primary |
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces an update on the approval status and availability of ProAmatine (midodrine HCl), a medicine approved for the treatment of symptomatic orthostatic hypotension.
Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.
Deafness affects more than 250 million people worldwide. It typically involves the loss of sensory receptors, called hair cells, for their "tufts" of hair-like protrusions, and their associated neurons.
While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Huda Y Alsheikh, MD 8881 Fletcher Pkwy Ste 200, La Mesa, CA 91942-3135 Ph: (619) 464-6434 | Dr Huda Y Alsheikh, MD 8881 Fletcher Pkwy Ste 200, La Mesa, CA 91942-3135 Ph: (619) 464-6434 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces an update on the approval status and availability of ProAmatine (midodrine HCl), a medicine approved for the treatment of symptomatic orthostatic hypotension.
Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.
Deafness affects more than 250 million people worldwide. It typically involves the loss of sensory receptors, called hair cells, for their "tufts" of hair-like protrusions, and their associated neurons.
While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
› Verified 5 days ago
Lisa Lew Gabhart, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 858-499-2600 | |
Li-wen Jen, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 858-499-2600 | |
John M. Goldenring, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 858-499-2600 | |
Sara Susanne Rourke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 858-499-2701 | |
Kristen Leanne Empie, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8881 Fletcher Pkwy Ste 200, La Mesa, CA 91942 Phone: 619-464-6434 Fax: 619-464-5109 | |
Paul Michael Imus, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8881 Fletcher Pkwy Ste 200, La Mesa, CA 91942 Phone: 619-464-6434 Fax: 619-464-5109 | |
Dr. Eric John Meyer Reed, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 858-499-2701 |